🇨🇦 Canada Country × Condition
parkinson disease Clinical Trials in Canada
Active clinical trials for parkinson disease with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 6 // Recruiting: 6 Phases: Phase 2 // Updated: Daily
Total Trials
6
Recruiting Now
6
Country
🇨🇦 Canada
Active Trials in Canada (6)
NCT04426786
Recruiting
Exercise & Brain Energetics in PD
Enrollment
40 pts
Country
🇨🇦 Canada
Pacific Parkinson's Research Centre
View Trial → NCT05568498 Phase 2
Recruiting
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease
Enrollment
60 pts
Country
🇨🇦 Canada
University of British Columbia
View Trial → NCT05826457
Recruiting
North American Prodromal Synucleinopathy Consortium Stage 2
Enrollment
500 pts
Country
🇨🇦 Canada
Washington University School of Med...
View Trial → NCT05971459
Recruiting
A Study of the Efficacy of IAMT as an Assessment Tool for Prediction of Progression of Parkinson's Disease
Enrollment
50 pts
Country
🇨🇦 Canada
Wilfrid Laurier University
View Trial → NCT04284436
Recruiting
Study in Parkinson Disease of Exercise
Enrollment
370 pts
Country
🇨🇦 Canada
Northwestern University
View Trial → NCT06518824
Recruiting
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
Enrollment
27 pts
Country
🇨🇦 Canada
University of British Columbia
View Trial → Frequently Asked Questions
How many parkinson disease clinical trials are active in Canada?
There are currently 6 active clinical trials for parkinson disease with sites in Canada, of which 6 are actively recruiting patients.
How can I join a parkinson disease clinical trial in Canada?
To join a parkinson disease clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in Canada?
Active parkinson disease trials in Canada span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.